Genoskin is a biotech company founded in 2011 located in Toulouse, France and Boston, MA. We have developed technology to maintain human tissues alive and functional for 7+ days. Genoskin provides ready-to-use, standardized, immunocompetent and injectable human ex-vivo skin models. As a Contract Research Organization, we also leverage our immunology expertise, assays and platforms to extend the research abilities of our sponsors.
Website:
www.genoskin.com
Contact:
contact@genoskin.com
Country:
United States, United Kingdom, Germany, Canada, Japan, France, Switzerland, India, Sweden, Belgium, Austria, Australia, Finland, Italy, Spain, Taiwan, The Netherlands